Evolutionary algorithms with preference polyhedron for interval multi-objective optimization problems

D. Gong,Jing Sun,Xin-fang Ji

DOI: https://doi.org/10.1016/j.ins.2013.01.020

IF: 8.1

2013-06-01

Information Sciences

Abstract:

What problem does this paper attempt to address?

The SINEB1 Element in the Long Non-Coding RNA Malat1 is Necessary for TDP-43 Proteostasis

Tuan M. Nguyen,Elena B. Kabotyanski,Lucas C. Reineke,Jiaofang Shao,Feng Xiong,Joo-Hyung Lee,Julien Dubrulle,Hannah Johnson,Fabio Stossi,Phoebe S. Tsoi,Kyoung-Jae Choi,Alexander G. Ellis,Na Zhao,Jin Cao,Oluwatoyosi Adewunmi,Josephine C. Ferreon,Allan Chris M. Ferreon,Joel R. Neilson,Michael A. Mancini,Xi Chen,Jongchan Kim,Li Ma,Wenbo Li,Jeffrey M. Rosen

DOI: https://doi.org/10.1093/nar/gkz1176

2018-01-01

Abstract:Transposable elements (TEs) comprise a large proportion of long non-coding RNAs (lncRNAs). Here, we employed CRISPR to delete a short interspersed nuclear element (SINE) in Malat1, a cancer-associated lncRNA, to investigate its significance in cellular physiology. We show that Malat1 with a SINE deletion forms diffuse nuclear speckles and is frequently translocated to the cytoplasm. SINE-deleted cells exhibit an activated unfolded protein response and PKR and markedly increased DNA damage and apoptosis caused by dysregulation of TDP-43 localization and formation of cytotoxic inclusions. TDP-43 binds stronger to Malat1 without the SINE and is likely 'hijacked' by cytoplasmic Malat1 to the cytoplasm, resulting in the depletion of nuclear TDP-43 and redistribution of TDP-43 binding to repetitive element transcripts and mRNAs encoding mitotic and nuclear-cytoplasmic regulators. The SINE promotes Malat1 nuclear retention by facilitating Malat1 binding to HNRNPK, a protein that drives RNA nuclear retention, potentially through direct interactions of the SINE with KHDRBS1 and TRA2A, which bind to HNRNPK. Losing these RNA-protein interactions due to the SINE deletion likely creates more available TDP-43 binding sites on Malat1 and subsequent TDP-43 aggregation. These results highlight the significance of lncRNA TEs in TDP-43 proteostasis with potential implications in both cancer and neurodegenerative diseases.
RNA/DNA Binding Protein TDP43 Regulates DNA Mismatch Repair Genes with Implications for Genome Stability

Vincent Provasek,Albino Bacolla,Suganya Rangaswamy,Joy Mitra,Manohar Kodavati,Issa Yusuf,Vikas Malojirao,Velmarini Vasquez,Gavin W Britz,Guo-Min Li,Zuoshang Xu,Sankar Mitra,Ralph M Garruto,John Tainer,Muralidhar Hegde

DOI: https://doi.org/10.1101/2024.05.16.594552

2024-05-17

Abstract:TDP43 is an RNA/DNA binding protein increasingly recognized for its role in neurodegenerative conditions including amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). As characterized by its aberrant nuclear export and cytoplasmic aggregation, TDP43 proteinopathy is a hallmark feature in over 95% of ALS/FTD cases, leading to the formation of detrimental cytosolic aggregates and a reduction in nuclear functionality within neurons. Building on our prior work linking TDP43 proteinopathy to the accumulation of DNA double-strand breaks (DSBs) in neurons, the present investigation uncovers a novel regulatory relationship between TDP43 and DNA mismatch repair (MMR) gene expressions. Here, we show that TDP43 depletion or overexpression directly affects the expression of key MMR genes. Alterations include MLH1, MSH2, MSH3, MSH6, and PMS2 levels across various primary cell lines, independent of their proliferative status. Our results specifically establish that TDP43 selectively influences the expression of MLH1 and MSH6 by influencing their alternative transcript splicing patterns and stability. We furthermore find aberrant MMR gene expression is linked to TDP43 proteinopathy in two distinct ALS mouse models and post-mortem brain and spinal cord tissues of ALS patients. Notably, MMR depletion resulted in the partial rescue of TDP43 proteinopathy-induced DNA damage and signaling. Moreover, bioinformatics analysis of the TCGA cancer database reveals significant associations between TDP43 expression, MMR gene expression, and mutational burden across multiple cancers. Collectively, our findings implicate TDP43 as a critical regulator of the MMR pathway and unveil its broad impact on the etiology of both neurodegenerative and neoplastic pathologies.

Biochemistry
TDP43 autoregulation gives rise to shortened isoforms that are tightly controlled by both transcriptional and post-translational mechanisms

Megan M Dykstra,Kaitlin Weskamp,Nicolas B Gomez,Jacob Waksmacki,Elizabeth M Tank,M. Rebecca Glineburg,Allison Snyder,Emile Pinarbasi,Michael Bekier,Xingli Li,Jen Bai,Shameena Shahzad,Juno Nedumaran,Clare Wieland,Corey Stewart,Sydney Willey,Nikolas Grotewold,Jonathon McBride,John Moran,Aditya Suryakumar,Michael Lucas,Pete Tessier,Michael Ward,Peter Todd,Sami Barmada

DOI: https://doi.org/10.1101/2024.07.02.601776

2024-07-04

Abstract:The nuclear RNA-binding protein TDP43 is integrally involved in the pathogenesis of amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). Previous studies uncovered N-terminal TDP43 isoforms that are predominantly cytosolic in localization, highly prone to aggregation, and enriched in susceptible spinal motor neurons. In healthy cells, however, these shortened (s)TDP43 isoforms are difficult to detect in comparison to full-length (fl)TDP43, raising questions regarding their origin and selective regulation. Here, we show that sTDP43 is created as a byproduct of TDP43 autoregulation and cleared by nonsense mediated RNA decay (NMD). The sTDP43-encoding transcripts that escape NMD can lead to toxicity but are rapidly degraded post-translationally. Circumventing these regulatory mechanisms by overexpressing sTDP43 results in neurodegeneration in vitro and in vivo via N-terminal oligomerization and impairment of flTDP43 splicing activity, in addition to RNA binding-dependent gain-of-function toxicity. Collectively, these studies highlight endogenous mechanisms that tightly regulate sTDP43 expression and provide insight into the consequences of aberrant sTDP43 accumulation in disease.

Neuroscience
RNA-binding deficient TDP-43 drives cognitive decline in a mouse model of TDP-43 proteinopathy

Julie C Necarsulmer,Jeremy M Simon,Baggio A Evangelista,Youjun Chen,Xu Tian,Sara Nafees,Ariana B Marquez,Huijun Jiang,Ping Wang,Deepa Ajit,Viktoriya D Nikolova,Kathryn M Harper,J Ashley Ezzell,Feng-Chang Lin,Adriana S Beltran,Sheryl S Moy,Todd J Cohen,Julie Necarsulmer,Jeremy Simon,Baggio Evangelista,Ariana Marquez Gonzalez,Huijin Jiang,Viktoriya Nikolova,Kathryn Harper,Jennifer Ezzell,Feng-Chang,Adriana Beltran,Sheryl Moy,Todd Cohen

DOI: https://doi.org/10.7554/elife.85921

IF: 7.7

2023-10-12

eLife

Abstract:TDP-43 proteinopathies including frontotemporal lobar degeneration (FTLD) and amyotrophic lateral sclerosis (ALS) are neurodegenerative disorders characterized by aggregation and mislocalization of the nucleic acid-binding protein TDP-43 and subsequent neuronal dysfunction. Here, we developed endogenous models of sporadic TDP-43 proteinopathy based on the principle that disease-associated TDP-43 acetylation at lysine 145 (K145) alters TDP-43 conformation, impairs RNA-binding capacity, and induces downstream mis-regulation of target genes. Expression of acetylation-mimic TDP-43 K145Q resulted in stress-induced nuclear TDP-43 foci and loss of TDP-43 function in primary mouse and human-induced pluripotent stem cell (hiPSC)-derived cortical neurons. Mice harboring the TDP-43 K145Q mutation recapitulated key hallmarks of FTLD, including progressive TDP-43 phosphorylation and insolubility, TDP-43 mis-localization, transcriptomic and splicing alterations, and cognitive dysfunction. Our study supports a model in which TDP-43 acetylation drives neuronal dysfunction and cognitive decline through aberrant splicing and transcription of critical genes that regulate synaptic plasticity and stress response signaling. The neurodegenerative cascade initiated by TDP-43 acetylation recapitulates many aspects of human FTLD and provides a new paradigm to further interrogate TDP-43 proteinopathies.

biology
RNA-mediated ribonucleoprotein assembly controls TDP-43 nuclear retention

Patricia M Dos Passos,Erandika H Hemamali,Lohany D Mamede,Lindsey R Hayes,Yuna M Ayala,Patricia M. dos Passos,Erandika H. Hemamali,Lohany D. Mamede,Lindsey R. Hayes,Yuna M. Ayala

DOI: https://doi.org/10.1371/journal.pbio.3002527

IF: 9.8

2024-03-02

PLoS Biology

Abstract:TDP-43 is an essential RNA-binding protein strongly implicated in the pathogenesis of neurodegenerative disorders characterized by cytoplasmic aggregates and loss of nuclear TDP-43. The protein shuttles between nucleus and cytoplasm, yet maintaining predominantly nuclear TDP-43 localization is important for TDP-43 function and for inhibiting cytoplasmic aggregation. We previously demonstrated that specific RNA binding mediates TDP-43 self-assembly and biomolecular condensation, requiring multivalent interactions via N- and C-terminal domains. Here, we show that these complexes play a key role in TDP-43 nuclear retention. TDP-43 forms macromolecular complexes with a wide range of size distribution in cells and we find that defects in RNA binding or inter-domain interactions, including phase separation, impair the assembly of the largest species. Our findings suggest that recruitment into these macromolecular complexes prevents cytoplasmic egress of TDP-43 in a size-dependent manner. Our observations uncover fundamental mechanisms controlling TDP-43 cellular homeostasis, whereby regulation of RNA-mediated self-assembly modulates TDP-43 nucleocytoplasmic distribution. Moreover, these findings highlight pathways that may be implicated in TDP-43 proteinopathies and identify potential therapeutic targets.

biochemistry & molecular biology,biology
A single N‐terminal phosphomimic disrupts TDP‐43 polymerization, phase separation, and RNA splicing

Ailin Wang,Alexander E Conicella,Hermann Broder Schmidt,Erik W Martin,Shannon N Rhoads,Ashley N Reeb,Amanda Nourse,Daniel Ramirez Montero,Veronica H Ryan,Rajat Rohatgi,Frank Shewmaker,Mandar T Naik,Tanja Mittag,Yuna M Ayala,Nicolas L Fawzi

DOI: https://doi.org/10.15252/embj.201797452

2018-02-09

The EMBO Journal

Abstract:TDP-43 is an RNA-binding protein active in splicing that concentrates into membraneless ribonucleoprotein granules and forms aggregates in amyotrophic lateral sclerosis (ALS) and Alzheimer's disease. Although best known for its predominantly disordered C-terminal domain which mediates ALS inclusions, TDP-43 has a globular N-terminal domain (NTD). Here, we show that TDP-43 NTD assembles into head-to-tail linear chains and that phosphomimetic substitution at S48 disrupts TDP-43 polymeric assembly, discourages liquid-liquid phase separation (LLPS) in vitro, fluidizes liquid-liquid phase separated nuclear TDP-43 reporter constructs in cells, and disrupts RNA splicing activity. Finally, we present the solution NMR structure of a head-to-tail NTD dimer comprised of two engineered variants that allow saturation of the native polymerization interface while disrupting higher-order polymerization. These data provide structural detail for the established mechanistic role of the well-folded TDP-43 NTD in splicing and link this function to LLPS. In addition, the fusion-tag solubilized, recombinant form of TDP-43 full-length protein developed here will enable future phase separation and in vitro biochemical assays on TDP-43 function and interactions that have been hampered in the past by TDP-43 aggregation.
Disgust faces, basal ganglia and obsessive-compulsive disorder: Some strange brainfellows

P. Rozin

DOI: https://doi.org/10.1016/S1364-6613(97)01102-9

IF: 19.9

1997-12-01

Trends in Cognitive Sciences

Abstract:
Loss of TDP-43 function contributes to genomic instability in amyotrophic lateral sclerosis

Minggang Fang,Sara K Deibler,Alissa L Nana,Sarat C Vatsavayai,Shahid Banday,You Zhou,Sandra Almeida,Alexandra Weiss,Robert H Brown,William W Seeley,Fen-Biao Gao,Michael R Green

DOI: https://doi.org/10.3389/fnins.2023.1251228

2023-10-02

Abstract:A common pathological hallmark of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) is the cytoplasmic mislocalization and aggregation of the DNA/RNA-binding protein TDP-43, but how loss of nuclear TDP-43 function contributes to ALS and FTD pathogenesis remains largely unknown. Here, using large-scale RNAi screening, we identify TARDBP, which encodes TDP-43, as a gene whose loss-of-function results in elevated DNA mutation rate and genomic instability. Consistent with this finding, we observe increased DNA damage in induced pluripotent stem cells (iPSCs) and iPSC-derived post-mitotic neurons generated from ALS patients harboring TARDBP mutations. We find that the increase in DNA damage in ALS iPSC-derived neurons is due to defects in two major pathways for DNA double-strand break repair: non-homologous end joining and homologous recombination. Cells with defects in DNA repair are sensitive to DNA damaging agents and, accordingly, we find that ALS iPSC-derived neurons show a marked reduction in survival following treatment with a DNA damaging agent. Importantly, we find that increased DNA damage is also observed in neurons with nuclear TDP-43 depletion from ALS/FTD patient brain tissues. Collectively, our results demonstrate that ALS neurons with loss of nuclear TDP-43 function have elevated levels of DNA damage and contribute to the idea that genomic instability is a defining pathological feature of ALS/FTD patients with TDP-43 pathology.
RNA-binding properties orchestrate TDP-43 homeostasis through condensate formation in vivo

Natalie M Scherer,Cindy Maurel,Matthew S Graus,Luke McAlary,Grant Richter,Rowan A W Radford,Alison Hogan,Emily K Don,Albert Lee,Justin Yerbury,Mathias Francois,Roger S Chung,Marco Morsch,Matthew S Graus,Rowan A W Radford,Emily K Don,Roger S Chung

DOI: https://doi.org/10.1093/nar/gkae112

IF: 14.9

2024-02-23

Nucleic Acids Research

Abstract:Insoluble cytoplasmic aggregate formation of the RNA-binding protein TDP-43 is a major hallmark of neurodegenerative diseases including Amyotrophic Lateral Sclerosis. TDP-43 localizes predominantly in the nucleus, arranging itself into dynamic condensates through liquid–liquid phase separation (LLPS). Mutations and post-translational modifications can alter the condensation properties of TDP-43, contributing to the transition of liquid-like biomolecular condensates into solid-like aggregates. However, to date it has been a challenge to study the dynamics of this process in vivo. We demonstrate through live imaging that human TDP-43 undergoes nuclear condensation in spinal motor neurons in a living animal. RNA-binding deficiencies as well as post-translational modifications can lead to aberrant condensation and altered TDP-43 compartmentalization. Single-molecule tracking revealed an altered mobility profile for RNA-binding deficient TDP-43. Overall, these results provide a critically needed in vivo characterization of TDP-43 condensation, demonstrate phase separation as an important regulatory mechanism of TDP-43 accessibility, and identify a molecular mechanism of how functional TDP-43 can be regulated.

biochemistry & molecular biology
Proteomics elucidating physiological and pathological functions of TDP-43

Jorge García Morato,Christian Johannes Gloeckner,Philipp J Kahle

DOI: https://doi.org/10.1002/pmic.202200410

PROTEOMICS

Abstract:Trans-activation response DNA binding protein of 43 kDa (TDP-43) regulates a great variety of cellular processes in the nucleus and cytosol. In addition, a defined subset of neurodegenerative diseases is characterized by nuclear depletion of TDP-43 as well as cytosolic mislocalization and aggregation. To perform its diverse functions TDP-43 can associate with different ribonucleoprotein complexes. Combined with transcriptomics, MS interactome studies have unveiled associations between TDP-43 and the spliceosome machinery, polysomes and RNA granules. Moreover, the highly dynamic, low-valency interactions regulated by its low-complexity domain calls for innovative proximity labeling methodologies. In addition to protein partners, the analysis of post-translational modifications showed that they may play a role in the nucleocytoplasmic shuttling, RNA binding, liquid-liquid phase separation and protein aggregation of TDP-43. Here we review the various TDP-43 ribonucleoprotein complexes characterized so far, how they contribute to the diverse functions of TDP-43, and roles of post-translational modifications. Further understanding of the fluid dynamic properties of TDP-43 in ribonucleoprotein complexes, RNA granules, and self-assemblies will advance the understanding of RNA processing in cells and perhaps help to develop novel therapeutic approaches for TDPopathies.
Hetero-oligomerization of TDP-43 carboxy-terminal fragments with cellular proteins contributes to proteotoxicity

Akira Kitamura,Ai Fujimoto,Rei Kawashima,Yidan Lyu,Kotetsu Sasaki,Yuta Hamada,Kanami Moriya,Ayumi Kurata,Kazuho Takahashi,Reneé Brielmann,Laura C. Bott,Richard I. Morimoto,Masataka Kinjo

DOI: https://doi.org/10.1101/2022.05.22.493003

2024-05-02

Abstract:Carboxy terminal fragments (CTFs) of TDP-43 contain an intrinsically disordered region (IDR) and form cytoplasmic condensates containing amyloid fibrils. Such condensates are toxic and associated with pathogenicity in amyotrophic lateral sclerosis. However, the molecular details of how the domain of TDP-43 CTFs leads to condensation and cytotoxicity remain elusive. Here, we show that truncated RNA/DNA-recognition motif (RRM) at the N-terminus of TDP-43 CTFs leads to the structural transition of the IDR, whereas the IDR itself of TDP-43 CTFs is difficult to assemble even if they are proximate intermolecularly. Hetero-oligomers of TDP-43 CTFs that have recruited other proteins are more toxic than homo-oligomers, implicating loss-of-function of the endogenous proteins by such oligomers is associated with cytotoxicity. Furthermore, such toxicity of TDP-43 CTFs was cell-nonautonomously affected in the nematodes. Therefore, misfolding and oligomeric characteristics of the truncated RRM at the N-terminus of TDP-43 CTFs define their condensation properties and toxicity.

Molecular Biology
N-Terminal Fragments of TDP-43—In Vitro Analysis and Implication in the Pathophysiology of Amyotrophic Lateral Sclerosis and Frontotemporal Lobar Degeneration

Anna A. Chami,Léa Bedja-Iacona,Elodie Richard,Debora Lanznaster,Sylviane Marouillat,Charlotte Veyrat-Durebex,Christian R. Andres,Philippe Corcia,Hélène Blasco,Patrick Vourc'h

DOI: https://doi.org/10.3390/genes15091157

IF: 4.141

2024-09-03

Genes

Abstract:Abnormal cytoplasmic aggregates containing the TDP-43 protein and its fragments are present in the central nervous system of the majority of patients with amyotrophic lateral sclerosis (ALS) and in patients with frontotemporal lobar degeneration (FTLD). Many studies have focused on the C-terminal cleavage products of TDP-43 (CTFs), but few have focused on the N-terminal products (NTFs), yet several works and their protein domain composition support the involvement of NTFs in pathophysiology. In the present study, we expressed six NTFs of TDP-43, normally generated in vivo by proteases or following the presence of pathogenic genetic truncating variants, in HEK-293T cells. The N-terminal domain (NTD) alone was not sufficient to produce aggregates. Fragments containing the NTD and all or part of the RRM1 domain produced nuclear aggregates without affecting cell viability. Only large fragments also containing the RRM2 domain, with or without the glycine-rich domain, produced cytoplasmic aggregates. Of these, only NTFs containing even a very short portion of the glycine-rich domain caused a reduction in cell viability. Our results provide insights into the involvement of different TDP-43 domains in the formation of nuclear or cytoplasmic aggregates and support the idea that work on the development of therapeutic molecules targeting TDP-43 must also take into account NTFs and, in particular, those containing even a small part of the glycine-rich domain.

genetics & heredity
TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS/FTD

Ching-Chieh Chou,Yi Zhang,Mfon E. Umoh,Spencer W. Vaughan,Ileana Lorenzini,Feilin Liu,Melissa Sayegh,Paul G. Donlin-Asp,Yu Han Chen,Duc M. Duong,Nicholas T. Seyfried,Maureen A. Powers,Thomas Kukar,Chadwick M. Hales,Marla Gearing,Nigel J. Cairns,Kevin B. Boylan,Dennis W. Dickson,Rosa Rademakers,Yong-Jie Zhang,Leonard Petrucelli,Rita Sattler,Daniela C. Zarnescu,Jonathan D. Glass,Wilfried Rossoll

DOI: https://doi.org/10.1038/s41593-017-0047-3

IF: 25

2018-01-08

Nature Neuroscience

Abstract:The cytoplasmic mislocalization and aggregation of TAR DNA-binding protein-43 (TDP-43) is a common histopathological hallmark of the amyotrophic lateral sclerosis and frontotemporal dementia disease spectrum (ALS/FTD). However, the composition of aggregates and their contribution to the disease process remain unknown. Here we used proximity-dependent biotin identification (BioID) to interrogate the interactome of detergent-insoluble TDP-43 aggregates and found them enriched for components of the nuclear pore complex and nucleocytoplasmic transport machinery. Aggregated and disease-linked mutant TDP-43 triggered the sequestration and/or mislocalization of nucleoporins and transport factors, and interfered with nuclear protein import and RNA export in mouse primary cortical neurons, human fibroblasts and induced pluripotent stem cell–derived neurons. Nuclear pore pathology is present in brain tissue in cases of sporadic ALS and those involving genetic mutations in TARDBP and C9orf72. Our data strongly implicate TDP-43-mediated nucleocytoplasmic transport defects as a common disease mechanism in ALS/FTD.

neurosciences
Identification of genetic modifiers of TDP-43 neurotoxicity in Drosophila

Lihong Zhan,Keith A Hanson,Sang Hwa Kim,Apeksha Tare,Randal S Tibbetts

DOI: https://doi.org/10.1371/journal.pone.0057214

IF: 3.7

PLoS ONE

Abstract:Cytosolic aggregation of the nuclear RNA-binding protein TDP-43 is a histopathologic signature of degenerating neurons in amyotrophic lateral sclerosis (ALS), and mutations in the TARDBP gene encoding TDP-43 cause dominantly inherited forms of this condition. To understand the relationship between TDP-43 misregulation and neurotoxicity, we and others have used Drosophila as a model system, in which overexpression of either wild-type TDP-43 or its ALS-associated mutants in neurons is sufficient to induce neurotoxicity, paralysis, and early death. Using microarrays, we have examined gene expression patterns that accompany TDP-43-induced neurotoxicity in the fly system. Constitutive expression of TDP-43 in the Drosophila compound eye elicited widespread gene expression changes, with strong upregulation of cell cycle regulatory genes and genes functioning in the Notch intercellular communication pathway. Inducible expression of TDP-43 specifically in neurons elicited significant expression differences in a more restricted set of genes. Genes that were upregulated in both paradigms included SpindleB and the Notch target Hey, which appeared to be a direct TDP-43 target. Mutations that diminished activity of Notch or disrupted the function of downstream Notch target genes extended the lifespan of TDP-43 transgenic flies, suggesting that Notch activation was deleterious in this model. Finally, we showed that mutation of the nucleoporin Nup50 increased the lifespan of TDP-43 transgenic flies, suggesting that nuclear events contribute to TDP-43-dependent neurotoxicity. The combined findings identified pathways whose deregulation might contribute to TDP-43-induced neurotoxicity in Drosophila.
Axonal TDP-43 condensates drive neuromuscular junction disruption through inhibition of local synthesis of nuclear encoded mitochondrial proteins

Topaz Altman,Ariel Ionescu,Amjad Ibraheem,Dominik Priesmann,Tal Gradus-Pery,Luba Farberov,Gayster Alexandra,Natalia Shelestovich,Ruxandra Dafinca,Noam Shomron,Florence Rage,Kevin Talbot,Michael E Ward,Amir Dori,Marcus Krüger,Eran Perlson

DOI: https://doi.org/10.1038/s41467-021-27221-8

2021-11-25

Abstract:Mislocalization of the predominantly nuclear RNA/DNA binding protein, TDP-43, occurs in motor neurons of ~95% of amyotrophic lateral sclerosis (ALS) patients, but the contribution of axonal TDP-43 to this neurodegenerative disease is unclear. Here, we show TDP-43 accumulation in intra-muscular nerves from ALS patients and in axons of human iPSC-derived motor neurons of ALS patient, as well as in motor neurons and neuromuscular junctions (NMJs) of a TDP-43 mislocalization mouse model. In axons, TDP-43 is hyper-phosphorylated and promotes G3BP1-positive ribonucleoprotein (RNP) condensate assembly, consequently inhibiting local protein synthesis in distal axons and NMJs. Specifically, the axonal and synaptic levels of nuclear-encoded mitochondrial proteins are reduced. Clearance of axonal TDP-43 or dissociation of G3BP1 condensates restored local translation and resolved TDP-43-derived toxicity in both axons and NMJs. These findings support an axonal gain of function of TDP-43 in ALS, which can be targeted for therapeutic development.
Mitigation of TDP-43 toxic phenotype by an RGNEF fragment in amyotrophic lateral sclerosis models

Cristian A Droppelmann,Danae Campos-Melo,Veronica Noches,Crystal McLellan,Robert Szabla,Taylor A Lyons,Hind Amzil,Benjamin Withers,Brianna Kaplanis,Kirti S Sonkar,Anne Simon,Emanuele Buratti,Murray Junop,Jamie M Kramer,Michael J Strong

DOI: https://doi.org/10.1093/brain/awae078

IF: 14.5

2024-05-15

Brain

Abstract:Aggregation of the RNA-binding protein TAR DNA binding protein (TDP-43) is a hallmark of TDP-proteinopathies including amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). As TDP-43 aggregation and dysregulation are causative of neuronal death, there is a special interest in targeting this protein as a therapeutic approach. Previously, we found that TDP-43 extensively co-aggregated with the dual function protein GEF (guanine exchange factor) and RNA-binding protein rho guanine nucleotide exchange factor (RGNEF) in ALS patients. Here, we show that an N-terminal fragment of RGNEF (NF242) interacts directly with the RNA recognition motifs of TDP-43 competing with RNA and that the IPT/TIG domain of NF242 is essential for this interaction. Genetic expression of NF242 in a fruit fly ALS model overexpressing TDP-43 suppressed the neuropathological phenotype increasing lifespan, abolishing motor defects and preventing neurodegeneration. Intracerebroventricular injections of AAV9/NF242 in a severe TDP-43 murine model (rNLS8) improved lifespan and motor phenotype, and decreased neuroinflammation markers. Our results demonstrate an innovative way to target TDP-43 proteinopathies using a protein fragment with a strong affinity for TDP-43 aggregates and a mechanism that includes competition with RNA sequestration, suggesting a promising therapeutic strategy for TDP-43 proteinopathies such as ALS and FTD.

neurosciences,clinical neurology
Elevated nuclear TDP-43 induces constitutive exon skipping

Rogger P. Carmen-Orozco,William Tsao,Yingzhi Ye,Irika R. Sinha,Koping Chang,Vickie T. Trinh,William Chung,Kyra Bowden,Juan C. Troncoso,Seth Blackshaw,Lindsey R. Hayes,Shuying Sun,Philip C. Wong,Jonathan P. Ling

DOI: https://doi.org/10.1186/s13024-024-00732-w

2024-06-12

Molecular Neurodegeneration

Abstract:Cytoplasmic inclusions and loss of nuclear TDP-43 are key pathological features found in several neurodegenerative disorders, suggesting both gain- and loss-of-function mechanisms of disease. To study gain-of-function, TDP-43 overexpression has been used to generate in vitro and in vivo model systems.

neurosciences
Targeting 14-3-3θ-mediated TDP-43 pathology in amyotrophic lateral sclerosis and frontotemporal dementia mice

Yazi D Ke,Annika van Hummel,Carol Au,Gabriella Chan,Wei Siang Lee,Julia van der Hoven,Magdalena Przybyla,Yuanyuan Deng,Miheer Sabale,Nicolle Morey,Josefine Bertz,Astrid Feiten,Stefania Ippati,Claire H Stevens,Shu Yang,Amadeus Gladbach,Nikolas K Haass,Jillian J Kril,Ian P Blair,Fabien Delerue,Lars M Ittner,Yazi D. Ke,Claire H. Stevens,Nikolas K. Haass,Jillian J. Kril,Ian P. Blair,Lars M. Ittner

DOI: https://doi.org/10.1016/j.neuron.2024.01.022

IF: 16.2

2024-02-01

Neuron

Abstract:Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are characterized by cytoplasmic deposition of the nuclear TAR-binding protein 43 (TDP-43). Although cytoplasmic re-localization of TDP-43 is a key event in the pathogenesis of ALS/FTD, the underlying mechanisms remain unknown. Here, we identified a non-canonical interaction between 14-3-3θ and TDP-43, which regulates nuclear-cytoplasmic shuttling. Neuronal 14-3-3θ levels were increased in sporadic ALS and FTD with TDP-43 pathology. Pathogenic TDP-43 showed increased interaction with 14-3-3θ, resulting in cytoplasmic accumulation, insolubility, phosphorylation, and fragmentation of TDP-43, resembling pathological changes in disease. Harnessing this increased affinity of 14-3-3θ for pathogenic TDP-43, we devised a gene therapy vector targeting TDP-43 pathology, which mitigated functional deficits and neurodegeneration in different ALS/FTD mouse models expressing mutant or non-mutant TDP-43, including when already symptomatic at the time of treatment. Our study identified 14-3-3θ as a mediator of cytoplasmic TDP-43 localization with implications for ALS/FTD pathogenesis and therapy.

neurosciences
Axon guidance genes are regulated by TDP-43 and RGNEF through long-intron removal

Yasmine Abbassi,Sara Cappelli,Eugenio Spagnolo,Alice Gennari,Giulia Visani,Simone Barattucci,Francesca Paron,Cristiana Stuani,Cristian A Droppelmann,Michael J Strong,Emanuele Buratti

DOI: https://doi.org/10.1096/fj.202400743RR

2024-10-15

Abstract:Rho guanine nucleotide exchange factor (RGNEF) is a guanine nucleotide exchange factor (GEF) mainly involved in regulating the activity of Rho-family GTPases. It is a bi-functional protein, acting both as a guanine exchange factor and as an RNA-binding protein. RGNEF is known to act as a destabilizing factor of neurofilament light chain RNA (NEFL) and it could potentially contribute to their sequestration in nuclear cytoplasmic inclusions. Most importantly, RGNEF inclusions in the spinal motor neurons of ALS patients have been shown to co-localize with inclusions of TDP-43, the major well-known RNA-binding protein aggregating in the brain and spinal cord of human patients. Therefore, it can be hypothesized that loss-of-function of both proteins following aggregation may contribute to motor neuron death/survival in ALS patients. To further characterize their relationship, we have compared the transcriptomic profiles of neuronal cells depleted of TDP-43 and RGNEF and show that these two factors predominantly act in an antagonistic manner when regulating the expression of axon guidance genes. From a mechanistic point of view, our experiments show that the effect of these genes on the processivity of long introns can explain their mode of action. Taken together, our results show that loss-of-function of factors co-aggregating with TDP-43 can potentially affect the expression of commonly regulated neuronal genes in a very significant manner, potentially acting as disease modifiers. This finding further highlights that neurodegenerative processes at the RNA level are the result of combinatorial interactions between different RNA-binding factors that can be co-aggregated in neuronal cells. A deeper understanding of these complex scenarios may lead to a better understanding of pathogenic mechanisms occurring in patients, where more than one specific protein may be aggregating in their neurons.

Evolutionary algorithms with preference polyhedron for interval multi-objective optimization problems

The SINEB1 Element in the Long Non-Coding RNA Malat1 is Necessary for TDP-43 Proteostasis

RNA/DNA Binding Protein TDP43 Regulates DNA Mismatch Repair Genes with Implications for Genome Stability

TDP43 autoregulation gives rise to shortened isoforms that are tightly controlled by both transcriptional and post-translational mechanisms

RNA-binding deficient TDP-43 drives cognitive decline in a mouse model of TDP-43 proteinopathy

RNA-mediated ribonucleoprotein assembly controls TDP-43 nuclear retention

A single N‐terminal phosphomimic disrupts TDP‐43 polymerization, phase separation, and RNA splicing

Disgust faces, basal ganglia and obsessive-compulsive disorder: Some strange brainfellows

Loss of TDP-43 function contributes to genomic instability in amyotrophic lateral sclerosis

RNA-binding properties orchestrate TDP-43 homeostasis through condensate formation in vivo

Proteomics elucidating physiological and pathological functions of TDP-43

Hetero-oligomerization of TDP-43 carboxy-terminal fragments with cellular proteins contributes to proteotoxicity

N-Terminal Fragments of TDP-43—In Vitro Analysis and Implication in the Pathophysiology of Amyotrophic Lateral Sclerosis and Frontotemporal Lobar Degeneration

TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS/FTD

Identification of genetic modifiers of TDP-43 neurotoxicity in Drosophila

Axonal TDP-43 condensates drive neuromuscular junction disruption through inhibition of local synthesis of nuclear encoded mitochondrial proteins

Mitigation of TDP-43 toxic phenotype by an RGNEF fragment in amyotrophic lateral sclerosis models

Elevated nuclear TDP-43 induces constitutive exon skipping

Targeting 14-3-3θ-mediated TDP-43 pathology in amyotrophic lateral sclerosis and frontotemporal dementia mice

Axon guidance genes are regulated by TDP-43 and RGNEF through long-intron removal